Triple-Negative Breast Cancer
5 stories
-
healthAsthma Drug Shows Promise Against Hard-to-Treat Cancers
Montelukast, a common asthma drug, may help fight triple-negative breast cancer by reprogramming immune cells to attack tumors.
-
healthNew TNBC Study Reveals Drug-Resistant Cell States After Chemo
Researchers identify four distinct drug-tolerant cell states in triple-negative breast cancer, offering new targets to prevent recurrence.
-
healthBRCA1 Study Links Estrogen to DNA Damage and Cancer Risk
New research reveals estrogen causes DNA damage in BRCA1 mutation carriers, raising cancer risk and suggesting dietary prevention.
-
healthScientists Identify Molecule that Blocks Aggressive Breast Cancer Growth
New molecule SU212 targets cancer metabolism, showing promise in treating triple-negative breast cancer.
-
healthPersonalized mRNA Vaccines Show Durable T Cell Immunity Against TNBC
New research demonstrates individualized mRNA neoantigen vaccines successfully induce robust and lasting T cell responses in patients with triple-negative breast cancer (TNBC), offering a promising therapeutic avenue.